Summary

Persistence Market Research has recently released a comprehensive report on the worldwide market for plant-based vaccines. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global plant-based vaccines market from 2025 to 2032.

Key Insights:

• Plant-Based Vaccines Market Size (2025E): US$ 1,800.0 Mn
• Projected Market Value (2032F):US$ 3,905.20 Mn
• Global Market Growth Rate (CAGR 2025 to 2032): 11.70%

Plant-Based Vaccines Market - Report Scope:

Plant-based vaccines represent an innovative approach to immunization, leveraging genetically engineered plants to produce antigenic proteins that trigger immune responses in humans and animals. These vaccines offer several advantages over traditional vaccines, including cost-effectiveness, rapid production scalability, and reduced risk of contamination. The plant-based vaccines market caters to pharmaceutical companies, biotechnology firms, research institutions, and healthcare providers, addressing a wide range of infectious diseases, including influenza, COVID-19, human papillomavirus (HPV), and Ebola. Market growth is driven by increasing demand for sustainable and innovative vaccine production technologies, heightened awareness of emerging infectious diseases, and advancements in plant molecular farming.

Market Growth Drivers:

The global plant-based vaccines market is propelled by several key factors, including rising demand for alternative vaccine production methods that minimize dependency on traditional egg-based and cell culture systems. The rapid development of plant-based vaccines during the COVID-19 pandemic demonstrated the potential of this technology, accelerating research and investment in this field. Additionally, plant-based vaccines offer advantages such as lower production costs, reduced cold chain requirements, and scalability, making them ideal for addressing global vaccine shortages and improving accessibility in low-income regions. The increasing prevalence of zoonotic diseases and the need for efficient pandemic preparedness strategies further contribute to market expansion.

Market Restraints:

Despite promising growth prospects, the plant-based vaccines market faces challenges related to regulatory approval, public acceptance, and large-scale commercialization. Stringent regulations governing the clinical development and approval of plant-based vaccines create delays in market entry, affecting the commercialization timeline. Additionally, limited awareness and skepticism among healthcare professionals and consumers regarding the efficacy and safety of plant-based vaccines pose adoption challenges. Moreover, production scalability and the need for specialized infrastructure for plant molecular farming can increase operational costs, impacting market penetration in resource-limited settings. Addressing these barriers requires collaborative efforts among regulatory bodies, industry stakeholders, and healthcare organizations to promote confidence and acceptance of plant-based immunization strategies.

Market Opportunities:

The plant-based vaccines market presents significant growth opportunities driven by technological advancements, strategic partnerships, and expanding applications beyond infectious diseases. The development of plant-based vaccine platforms for cancer immunotherapy, veterinary vaccines, and therapeutic biologics expands market potential and stimulates innovation. Moreover, the integration of biopharmaceutical manufacturing with plant-based vaccine technology offers cost-effective solutions for large-scale vaccine production. Increased government and private-sector investments in biotechnology and plant molecular farming further support market expansion. Companies focusing on R&D, regulatory approvals, and strategic collaborations with healthcare organizations and vaccine manufacturers can capitalize on emerging opportunities and establish a strong market presence.

Key Questions Answered in the Report:

• What are the primary factors driving the growth of the plant-based vaccines market globally?
• Which diseases and applications are driving the adoption of plant-based vaccines across different healthcare settings?
• How are technological advancements reshaping the competitive landscape of the plant-based vaccines market?
• Who are the key players contributing to the plant-based vaccines market, and what strategies are they employing to maintain market relevance?
• What are the emerging trends and future prospects in the global plant-based vaccines market?

Competitive Intelligence and Business Strategy:

Leading players in the global plant-based vaccines market, including Medicago Inc., Kentucky BioProcessing, iBio Inc., and Icon Genetics GmbH, focus on innovation, strategic partnerships, and regulatory approvals to gain a competitive edge. These companies invest in research and development to enhance vaccine efficacy, improve production scalability, and ensure regulatory compliance. Collaborations with government agencies, biopharmaceutical firms, and academic institutions facilitate vaccine development and commercialization. Furthermore, efforts to expand clinical trials, secure funding, and optimize plant-based expression systems drive market growth and accelerate the adoption of plant-based vaccines.

Key Companies Profiled:

• Medicago Inc.
• Kentucky BioProcessing
• iBio Inc.
• Icon Genetics GmbH
• Leaf Expression Systems
• ProdiGene Inc.
• Fraunhofer Institute for Molecular Biology and Applied Ecology (IME)
• Canadian Biologics Inc.
• Baiya Phytopharm
• Angany Inc.

Key Segments of Plant-Based Vaccines Industry Research

By Type:
• Viral Vaccines
• Bacterial Vaccines

By Application:
• Influenza
• Zika Virus
• Ebola Virus

By Source:
• Maize
• Tobacco
• Potatoes

By Region:
• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East & Africa

ページTOPに戻る

Table of Contents

1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Market Innovation / Development Trends
4. Key Success Factors
4.1. Promotional Strategies, By Key Manufacturers
4.2. Key Regulations
4.3. Product Pipeline
4.4. Reimbursement Scenario
4.5. Value Chain Analysis
4.6. PESTEL Analysis
4.7. Porter’s Analysis
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global GDP Growth Outlook
5.1.2. Global Healthcare Expenditure Outlook
5.1.3. Global Recombinant Vaccines Market Outlook
5.2. Forecast Factors - Relevance & Impact
5.2.1. Cost of Production
5.2.2. Growing Development of Recombinant Vaccines
5.2.3. Increasing Incidence of Zoonotic Diseases
5.2.4. Rising Research and Development Activities
5.2.5. Growing Marketing Approvals for Plant-Based Vaccines
5.2.6. Cost of Vaccines
5.2.7. Emergence of the COVID-19 Pandemic
5.2.8. Large Clinical Pipeline
5.3. Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
6. COVID-19 Crisis Analysis
6.1. COVID-19 and Impact Analysis
6.1.1. By Source
6.1.2. By Type
6.1.3. By Application
6.1.4. By Country
6.2. 2025 Market Scenario
7. Global Plant-Based Vaccines Market Demand (in Value or Size in US$ Mn) Analysis 2019-2024 and Forecast, 2025-2032
7.1. Historical Market Value (US$ Mn) Analysis, 2019-2032
7.2. Current and Future Market Value (US$ Mn) Projections, 2025-2032
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis
8. Global Plant-Based Vaccines Market Analysis 2019-2024 and Forecast 2025-2032, By Source
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) Analysis By Source, 2019-2024
8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Source, 2025-2032
8.3.1. Maize
8.3.2. Tobacco
8.3.3. Potato
8.3.4. Others
8.4. Market Attractiveness Analysis By Source
9. Global Plant-Based Vaccines Market Analysis 2019-2024 and Forecast 2025-2032, By Type
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) Analysis By Type , 2019-2024
9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Type, 2025-2032
9.3.1. Viral Vaccine
9.3.2. Bacterial Vaccine
9.3.3. Others
9.4. Market Attractiveness Analysis By Type
10. Global Plant-Based Vaccines Market Analysis 2019-2024 and Forecast 2025-2032, By Application
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) Analysis By Application, 2019-2024
10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Application, 2025-2032
10.3.1. Influenza
10.3.2. Zika Virus
10.3.3. Ebola Virus
10.3.4. Others
10.4. Market Attractiveness Analysis By Application
11. Global Plant-Based Vaccines Market Analysis 2019-2024 and Forecast 2025-2032, By Region
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Mn) Analysis By Region, 2019-2024
11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Region, 2025-2032
11.3.1. North America
11.3.2. Latin America
11.3.3. Europe
11.3.4. East Asia
11.3.5. South Asia
11.3.6. Oceania
11.3.7. Middle East and Africa
11.4. Market Attractiveness Analysis By Region
12. North America Plant-Based Vaccines Market Analysis 2019-2024 and Forecast 2025-2032
12.1. Introduction
12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2032
12.3. Current and Future Market Size (US$ Mn) Analysis & Forecast By Market Taxonomy, 2025-2032
12.3.1. By Country
12.3.1.1. U.S.
12.3.1.2. Canada
12.3.2. By Source
12.3.3. By Type
12.3.4. By Application
12.4. Market Attractiveness Analysis
12.4.1. By Country
12.4.2. By Source
12.4.3. By Type
12.4.4. By Application
12.5. Market Trends
12.6. Key Market Participants - Intensity Mapping
12.7. Drivers and Restraints - Impact Analysis
12.8. Country Level Analysis & Forecast
12.8.1. U.S. Plant-Based Vaccines Market Analysis
12.8.1.1. Introduction
12.8.1.2. Market Analysis and Forecast By Market Taxonomy
12.8.1.2.1. By Country
12.8.1.2.2. By Source
12.8.1.2.3. By Type
12.8.1.2.4. By Application
12.8.2. Canada Plant-Based Vaccines Market Analysis
12.8.2.1. Introduction
12.8.2.2. Market Analysis and Forecast By Market Taxonomy
12.8.2.2.1. By Country
12.8.2.2.2. By Source
12.8.2.2.3. By Type
12.8.2.2.4. By Application
13. Latin America Plant-Based Vaccines Market Analysis 2019-2024 and Forecast 2025-2032
13.1. Introduction
13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2032
13.3. Current and Future Market Size (US$ Mn) Analysis & Forecast By Market Taxonomy, 2025-2032
13.3.1. By Country
13.3.1.1. Mexico
13.3.1.2. Brazil
13.3.1.3. Argentina
13.3.1.4. Rest of Latin America
13.3.1.4.1. By Country
13.3.1.4.2. By Source
13.3.1.4.3. By Type
13.3.1.4.4. By Application
13.4. Market Attractiveness Analysis
13.4.1. By Country
13.4.2. By Source
13.4.3. By Type
13.4.4. By Application
13.5. Market Trends
13.6. Key Market Participants - Intensity Mapping
13.7. Drivers and Restraints - Impact Analysis
13.8. Country Level Analysis & Forecast
13.8.1. Mexico Plant-Based Vaccines Market Analysis
13.8.1.1. Introduction
13.8.1.2. Market Analysis and Forecast By Market Taxonomy
13.8.1.2.1. By Source
13.8.1.2.2. By Type
13.8.1.2.3. By Application
13.8.2. Brazil Plant-Based Vaccines Market Analysis
13.8.2.1. Introduction
13.8.2.2. Market Analysis and Forecast By Market Taxonomy
13.8.2.2.1. By Country
13.8.2.2.2. By Source
13.8.2.2.3. By Type
13.8.2.2.4. By Application
13.8.3. Argentina Plant-Based Vaccines Market Analysis
13.8.3.1. Introduction
13.8.3.2. Market Analysis and Forecast By Market Taxonomy
13.8.3.2.1. By Source
13.8.3.2.2. By Type
13.8.3.2.3. By Application
14. Europe Plant-Based Vaccines Market Analysis 2019-2024 and Forecast 2025-2032
14.1. Introduction
14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2032
14.3. Current and Future Market Size (US$ Mn) Analysis & Forecast By Market Taxonomy, 2025-2032
14.3.1. By Country
14.3.1.1. Germany
14.3.1.2. Italy
14.3.1.3. France
14.3.1.4. U.K.
14.3.1.5. Spain
14.3.1.6. BENELUX
14.3.1.7. Russia
14.3.1.8. Rest of Europe
14.3.2. By Source
14.3.3. By Type
14.3.4. By Application
14.4. Market Attractiveness Analysis
14.4.1. By Country
14.4.2. By Source
14.4.3. By Type
14.4.4. By Application
14.5. Market Trends
14.6. Key Market Participants - Intensity Mapping
14.7. Drivers and Restraints - Impact Analysis
14.8. Country Level Analysis & Forecast
14.8.1. Germany Plant-Based Vaccines Market Analysis
14.8.1.1. Introduction
14.8.1.2. Market Analysis and Forecast By Market Taxonomy
14.8.1.2.1. By Source
14.8.1.2.2. By Type
14.8.1.2.3. By Application
14.8.2. Italy Plant-Based Vaccines Market Analysis
14.8.2.1. Introduction
14.8.2.2. Market Analysis and Forecast By Market Taxonomy
14.8.2.2.1. By Source
14.8.2.2.2. By Type
14.8.2.2.3. By Application
14.8.3. France Plant-Based Vaccines Market Analysis
14.8.3.1. Introduction
14.8.3.2. Market Analysis and Forecast By Market Taxonomy
14.8.3.2.1. By Source
14.8.3.2.2. By Type
14.8.3.2.3. By Application
14.8.4. U.K. Plant-Based Vaccines Market Analysis
14.8.4.1. Introduction
14.8.4.2. Market Analysis and Forecast By Market Taxonomy
14.8.4.2.1. By Source
14.8.4.2.2. By Type
14.8.4.2.3. By Application
14.8.5. Spain Plant-Based Vaccines Market Analysis
14.8.5.1. Introduction
14.8.5.2. Market Analysis and Forecast By Market Taxonomy
14.8.5.2.1. By Source
14.8.5.2.2. By Type
14.8.5.2.3. By Application
14.8.6. BENELUX Plant-Based Vaccines Market Analysis
14.8.6.1. Introduction
14.8.6.2. Market Analysis and Forecast By Market Taxonomy
14.8.6.2.1. By Source
14.8.6.2.2. By Type
14.8.6.2.3. By Application
14.8.7. Russia Plant-Based Vaccines Market Analysis
14.8.7.1. Introduction
14.8.7.2. Market Analysis and Forecast By Market Taxonomy
14.8.7.2.1. By Source
14.8.7.2.2. By Type
14.8.7.2.3. By Application
15. East Asia Plant-Based Vaccines Market Analysis 2019-2024 and Forecast 2025-2032
15.1. Introduction
15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2032
15.3. Current and Future Market Size (US$ Mn) Analysis & Forecast By Market Taxonomy, 2025-2032
15.3.1. By Country
15.3.1.1. China
15.3.1.2. Japan
15.3.1.3. South Korea
15.3.2. By Source
15.3.3. By Type
15.3.4. By Application
15.4. Market Attractiveness Analysis
15.4.1. By Country
15.4.2. By Source
15.4.3. By Type
15.4.4. By Application
15.5. Market Trends
15.6. Key Market Participants - Intensity Mapping
15.7. Drivers and Restraints - Impact Analysis
15.8. Country Level Analysis & Forecast
15.8.1. China Plant-Based Vaccines Market Analysis
15.8.1.1. Introduction
15.8.1.2. Market Analysis and Forecast By Market Taxonomy
15.8.1.2.1. By Source
15.8.1.2.2. By Type
15.8.1.2.3. By Application
15.8.2. Japan Plant-Based Vaccines Market Analysis
15.8.2.1. Introduction
15.8.2.2. Market Analysis and Forecast By Market Taxonomy
15.8.2.2.1. By Source
15.8.2.2.2. By Type
15.8.2.2.3. By Application
15.8.3. South Korea Plant-Based Vaccines Market Analysis
15.8.3.1. Introduction
15.8.3.2. Market Analysis and Forecast By Market Taxonomy
15.8.3.2.1. By Source
15.8.3.2.2. By Type
15.8.3.2.3. By Application
16. South Asia Plant-Based Vaccines Market Analysis 2019-2024 and Forecast 2025-2032
16.1. Introduction
16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2032
16.3. Current and Future Market Size (US$ Mn) Analysis & Forecast By Market Taxonomy, 2025-2032
16.3.1. By Country
16.3.1.1. India
16.3.1.2. Indonesia
16.3.1.3. Malaysia
16.3.1.4. Thailand
16.3.1.5. Rest of South Asia
16.3.2. By Source
16.3.3. By Type
16.3.4. By Application
16.4. Market Attractiveness Analysis
16.4.1. By Country
16.4.2. By Source
16.4.3. By Type
16.4.4. By Application
16.5. Market Trends
16.6. Key Market Participants - Intensity Mapping
16.7. Drivers and Restraints - Impact Analysis
16.8. Country Level Analysis & Forecast
16.8.1. India Plant-Based Vaccines Market Analysis
16.8.1.1. Introduction
16.8.1.2. Market Analysis and Forecast By Market Taxonomy
16.8.1.2.1. By Source
16.8.1.2.2. By Type
16.8.1.2.3. By Application
16.8.2. Indonesia Plant-Based Vaccines Market Analysis
16.8.2.1. Introduction
16.8.2.2. Market Analysis and Forecast By Market Taxonomy
16.8.2.2.1. By Source
16.8.2.2.2. By Type
16.8.2.2.3. By Application
16.8.3. Malaysia Plant-Based Vaccines Market Analysis
16.8.3.1. Introduction
16.8.3.2. Market Analysis and Forecast By Market Taxonomy
16.8.3.2.1. By Source
16.8.3.2.2. By Type
16.8.3.2.3. By Application
16.8.4. Thailand Plant-Based Vaccines Market Analysis
16.8.4.1. Introduction
16.8.4.2. Market Analysis and Forecast By Market Taxonomy
16.8.4.2.1. By Source
16.8.4.2.2. By Type
16.8.4.2.3. By Application
17. Oceania Plant-Based Vaccines Market 2019-2024 and Forecast 2025-2032
17.1. Introduction
17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2032
17.3. Current and Future Market Size (US$ Mn) Analysis & Forecast By Market Taxonomy, 2025-2032
17.3.1. By Country
17.3.1.1. Australia
17.3.1.2. New Zealand
17.3.2. By Source
17.3.3. By Type
17.3.4. By Application
17.4. Market Attractiveness Analysis
17.4.1. By Country
17.4.2. By Source
17.4.3. By Type
17.4.4. By Application
17.5. Key Market Participants - Intensity Mapping
17.6. Drivers and Restraints - Impact Analysis
17.7. Country Level Analysis & Forecast
17.7.1. Australia Plant-Based Vaccines Market Analysis
17.7.1.1. Introduction
17.7.1.2. Market Analysis and Forecast By Market Taxonomy
17.7.1.2.1. By Source
17.7.1.2.2. By Type
17.7.1.2.3. By Application
17.7.2. New Zealand Plant-Based Vaccines Market Analysis
17.7.2.1. Introduction
17.7.2.2. Market Analysis and Forecast By Market Taxonomy
17.7.2.2.1. By Source
17.7.2.2.2. By Type
17.7.2.2.3. By Application
18. Middle East and Africa (MEA) Plant-Based Vaccines Market Analysis 2019-2024 and Forecast 2025-2032
18.1. Introduction
18.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2032
18.3. Current and Future Market Size (US$ Mn) Analysis & Forecast By Market Taxonomy, 2025-2032
18.3.1. By Country
18.3.1.1. GCC Countries
18.3.1.2. Turkey
18.3.1.3. South Africa
18.3.1.4. North Africa
18.3.1.5. Rest of Middle East and Africa
18.3.2. By Source
18.3.3. By Type
18.3.4. By Application
18.4. Market Attractiveness Analysis
18.4.1. By Country
18.4.2. By Source
18.4.3. By Type
18.4.4. By Application
18.5. Market Trends
18.6. Key Market Participants - Intensity Mapping
18.7. Drivers and Restraints - Impact Analysis
18.8. Country Level Analysis & Forecast
18.8.1. GCC Countries Plant-Based Vaccines Market Analysis
18.8.1.1. Introduction
18.8.1.2. Market Analysis and Forecast By Market Taxonomy
18.8.1.2.1. By Source
18.8.1.2.2. By Type
18.8.1.2.3. By Application
18.8.2. Turkey Plant-Based Vaccines Market Analysis
18.8.2.1. Introduction
18.8.2.2. Market Analysis and Forecast By Market Taxonomy
18.8.2.2.1. By Source
18.8.2.2.2. By Type
18.8.2.2.3. By Application
18.8.3. South Africa Plant-Based Vaccines Market Analysis
18.8.3.1. Introduction
18.8.3.2. Market Analysis and Forecast By Market Taxonomy
18.8.3.2.1. By Source
18.8.3.2.2. By Type
18.8.3.2.3. By Application
18.8.4. North Africa Plant-Based Vaccines Market Analysis
18.8.4.1. Introduction
18.8.4.2. Market Analysis and Forecast By Market Taxonomy
18.8.4.2.1. By Source
18.8.4.2.2. By Type
18.8.4.2.3. By Application
19. Market Structure Analysis
19.1. Market Analysis By Tier of Companies
19.2. Market Concentration
19.3. Market Share Analysis (%) of Top Players
19.4. Market Presence Analysis
20. Competition Analysis
20.1. Competition Dashboard
20.2. Competition Benchmarking
20.3. Competition Deep Dive
20.3.1. Creative Biolabs
20.3.1.1. Overview
20.3.1.2. Product Portfolio
20.3.1.3. Sales Footprint
20.3.1.4. Key Financials
20.3.1.5. SWOT Analysis
20.3.1.6. Strategic Overview
20.3.2. Medicago Inc.
20.3.2.1. Overview
20.3.2.2. Product Portfolio
20.3.2.3. Sales Footprint
20.3.2.4. Key Financials
20.3.2.5. SWOT Analysis
20.3.2.6. Strategic Overview
20.3.3. iBio
20.3.3.1. Overview
20.3.3.2. Product Portfolio
20.3.3.3. Sales Footprint
20.3.3.4. Key Financials
20.3.3.5. SWOT Analysis
20.3.3.6. Strategic Overview
20.3.4. ICON
20.3.4.1. Overview
20.3.4.2. Product Portfolio
20.3.4.3. Sales Footprint
20.3.4.4. Key Financials
20.3.4.5. SWOT Analysis
20.3.4.6. Strategic Overview
20.3.5. EEA Consulting Engineers
20.3.5.1. Overview
20.3.5.2. Product Portfolio
20.3.5.3. Sales Footprint
20.3.5.4. Key Financials
20.3.5.5. SWOT Analysis
20.3.5.6. Strategic Overview
20.3.6. Kentucky BioProcessing, Inc.
20.3.6.1. Overview
20.3.6.2. Product Portfolio
20.3.6.3. Sales Footprint
20.3.6.4. Key Financials
20.3.6.5. SWOT Analysis
20.3.6.6. Strategic Overview
20.3.7. Baiya Phytopharm
20.3.7.1. Overview
20.3.7.2. Product Portfolio
20.3.7.3. Sales Footprint
20.3.7.4. Key Financials
20.3.7.5. SWOT Analysis
20.3.7.6. Strategic Overview
20.3.8. Protalix Biotherapeutics
20.3.8.1. Overview
20.3.8.2. Product Portfolio
20.3.8.3. Sales Footprint
20.3.8.4. Key Financials
20.3.8.5. SWOT Analysis
20.3.8.6. Strategic Overview
21. Assumptions and Acronyms Used
22. Research Methodology